95
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Disparities in survival for right-sided vs. left-sided colon cancers in young patients: a study based on the Surveillance, Epidemiology, and End Results database (1990–2014)

, , , , , , , , , & show all
Pages 1735-1747 | Published online: 26 Jun 2018

References

  • SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
  • LeeGHMalietzisGAskariABernardoDAl-HassiHOClarkSKIs right-sided colon cancer different to left-sided colorectal cancer? – a systematic reviewEur J Surg Oncol201541330030825468456
  • MeguidRASlidellMBWolfgangCLChangDCAhujaNIs there a difference in survival between right-versus left-sided colon cancers?Ann Surg Oncol20081592388239418622647
  • BenedixFKubeRMeyerFColon/Rectum Carcinomas (Primary Tumor) Study GroupComparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survivalDis Colon Rectum2010531576420010352
  • PetrelliFTomaselloGBorgonovoKPrognostic survival associated with left-sided vs right-sided colon cancer: a systematic review and meta-analysisJAMA Oncol Epub20161027
  • YahagiMOkabayashiKHasegawaHTsurutaMKitagawaYThe worse prognosis of right-sided compared with left-sided colon cancers: a systematic review and meta-analysisJ Gastrointest Surg201620364865526573851
  • WeissJMPfauPRO’ConnorESMortality by stage for right-versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results–Medicare dataJ Clin Oncol201129334401440921969498
  • KarimSBrennanKNanjiSBerrySRBoothCMAssociation between prognosis and tumor laterality in early-stage colon cancerJAMA Oncol20173101386139228594974
  • ArnoldDLuezaBDouillardJYPrognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trialsAnn Oncol20172881713172928407110
  • YouYNXingYFeigBWChangGJCormierJNYoung-onset colorectal cancer: is it time to pay attention?Arch Intern Med2012172328728922157065
  • AhnenDJWadeSWJonesWFThe increasing incidence of young-onset colorectal cancer: a call to actionMayo Clin Proc201489221622424393412
  • EdwardsBKWardEKohlerBAAnnual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future ratesCancer2010116354457319998273
  • KoblinskiJJandovaJNfonsamVDisparities in incidence of early- and late-onset colorectal cancer between Hispanics and Whites: a 10-year SEER database studyAm J Surg2018215458158528388972
  • BhandariAWoodhouseMGuptaSColorectal cancer is a leading cause of cancer incidence and mortality among adults younger than 50 years in the USA: a SEER-based analysis with comparison to other young-onset cancersJ Investig Med2017652311315
  • MyersEAFeingoldDLFordeKAArnellTJangJHWhelanRLColorectal cancer in patients under 50 years of age: a retrospective analysis of two institutions’ experienceWorld J Gastroenterol201319345651565724039357
  • BallesterVRashtakSBoardmanLClinical and molecular features of young-onset colorectal cancerWorld J Gastroenterol20162251736174426855533
  • ChanKKDassanayakeBDeenRYoung patients with colorectal cancer have poor survival in the first twenty months after operation and predictable survival in the medium and long-term: analysis of survival and prognostic markersWorld J Surg Oncol201088220840793
  • ZhaoLBaoFYanJPoor prognosis of young patients with colorectal cancer: a retrospective studyInt J Colorectal Dis20173281147115628389779
  • LiMLiJYZhaoALGuJDo young patients with colorectal cancer have a poorer prognosis than old patients?J Surg Res2011167223123621316708
  • YeoSAChewMHKohPKTangCLYoung colorectal carcinoma patients do not have a poorer prognosis: a comparative review of 2,426 casesTech Coloproctol201317665366123460362
  • WangRWangMJPingJClinicopathological features and survival outcomes of colorectal cancer in young versus elderly: a population-based cohort study of SEER 9 registries data (1988-2011)Medicine (Baltimore)20159435e140226334895
  • WarschkowRSulzMCMartiLBetter survival in right-sided versus left-sided stage I – III colon cancer patientsBMC Cancer20161655427464835
  • FearonERVogelsteinBA genetic model for colorectal tumorigenesisCell19906157597672188735
  • ShenHYangJHuangQDifferent treatment strategies and molecular features between right-sided and left-sided colon cancersWorld J Gastroenterol201521216470647826074686
  • JuoYYJohnstonFMZhangDYPrognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysisAnn Oncol201425122314232724718889
  • VedeldHMMerokMJeanmouginMCpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancersInt J Cancer2017141596797628542846
  • De RoockWJonkerDJDi NicolantonioFAssociation of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximabJAMA2010304161812182020978259
  • HeinemannVvon WeikersthalLFDeckerTFOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trialLancet Oncol201415101065107525088940
  • TejparSStintzingSCiardielloFPrognostic and predictive relevance of primary tumor location in patients with RAS wild-type metastatic colorectal cancer: retrospective analyses of the CRYSTAL and FIRE-3 trialsJAMA Oncol Epub20161010
  • RothADTejparSDelorenziMPrognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trialJ Clin Oncol201028346647420008640
  • PaiRKJayachandranPKoongACBRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic featuresAm J Surg Pathol201236574475222314188
  • OginoSShimaKMeyerhardtJAPredictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803Clin Cancer Res201218389090022147942
  • de CubaEMSnaebjornssonPHeidemanDAPrognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancersInt J Cancer201613851139114526376292
  • JernvallPMakinenMJKarttunenTJMakelaJVihkoPMicrosatellite instability: impact on cancer progression in proximal and distal colorectal cancersEur J Cancer199935219720110448259
  • De SmedtLLemahieuJPalmansSMicrosatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesisBr J Cancer2015113350050926068398
  • RibicCMSargentDJMooreMJTumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancerN Engl J Med2003349324725712867608
  • PopatSHubnerRHoulstonRSSystematic review of microsatellite instability and colorectal cancer prognosisJ Clin Oncol200523360961815659508
  • HemminkiAMecklinJPJarvinenHAaltonenLAJoensuuHMicrosatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapyGastroenterology2000119492192811040179
  • SamowitzWSCurtinKMaKNMicrosatellite instability in sporadic colon cancer is associated with an improved prognosis at the population levelCancer Epidemiol Biomarkers Prev200110991792311535541
  • MalesciALaghiLBianchiPReduced likelihood of metastases in patients with microsatellite-unstable colorectal cancerClin Cancer Res200713133831383917606714
  • KlingbielDSaridakiZRothADBosmanFTDelorenziMTejparSPrognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trialAnn Oncol201526112613225361982
  • O’ConnellJBMaggardMALivingstonEHYoCKColorectal cancer in the youngAm J Surg2004187334334815006562
  • LevinBLiebermanDAMcFarlandBAmerican Cancer Society Colorectal Cancer Advisory GroupUS Multi-Society Task ForceAmerican College of Radiology Colon Cancer CommitteeScreening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of RadiologyCA Cancer J Clin200858313016018322143
  • RhoYSGilabertMPolomKComparing clinical characteristics and outcomes of young-onset and late-onset colorectal cancer: an International Collaborative studyClin Colorectal Cancer201716433434228462853
  • De RosaMRegaDCostabileVThe biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized careTherap Adv Gastroenterol201696861886
  • MullerMFIbrahimAEArendsMJMolecular pathological classification of colorectal cancerVirchows Arch2016469212513427325016
  • LeeMSMenterDGKopetzSRight versus left colon cancer biology: integrating the consensus molecular subtypesJ Natl Compr Canc Netw201715341141928275039